Suven Life Sciences lost 5.84% to Rs 74.20 at 12:04 IST on BSE on profit booking after surging 45.79% in prior nine trading sessions.
Meanwhile, the BSE Sensex was up 3.82 points, or 0.02%, to 20,285.73
On BSE, 4.71 lakh shares were traded in the counter compared with average volume of 3.33 lakh shares in the past one quarter.
The stock hit a high of Rs 78.85 and a low of Rs 72.70 so far during the day. The stock hit a record high of Rs 83.40 on Tuesday, 12 November 2013. The stock hit a 52-week low of Rs 22 on 4 March 2013.
The stock had outperformed the market over the past one month till 12 November 2013, rising 70.01% compared with the Sensex's 1.20% fall. The scrip also outperformed the market in past one quarter, surging 176.01% as against Sensex's 7.05% rise.
The small-cap company has an equity capital of Rs 11.68 crore. Face value per share is Re 1.
More From This Section
Shares of Suven Life Sciences were on a roll recently, surging 45.79% in nine trading sessions to Rs 78.80 on 12 November 2013 from a recent low of Rs 54.05 on 30 October 2013. The rally caught momentum after the company reported blockbuster Q2 result during trading hours on 11 November 2013.
Suven Life Sciences' net profit surged 601.8% to Rs 45.55 crore on 201.3% spurt in net sales to Rs 151.41 crore in Q2 September 2013 over Q2 September 2012.
EBITDA (earnings before interest, taxes, depreciation and amortization) surged 550% to Rs 71.50 crore in Q2 September 2013 over Q2 September 2012.
Suven Life Sciences said the growth in profit was a result of one new product, in addition to two products already commercialised during the first quarter, totaling three products under CRAMS (contract research and manufacturing services).
Suven Life Sciences is in the business of design, manufacture and supply of bulk actives, drug intermediates & fine chemicals.
Powered by Capital Market - Live News